Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization
IntroductionInflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple disease...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1615816/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839618351786098688 |
---|---|
author | Adriana A. Rodriguez Alvarez Isabella F. Cieri Mounika Naidu Boya Shiv Patel Aniket Agrawal Sasha P. Suarez Ferreira Christianah Alli Shruti Sharma Anahita Dua |
author_facet | Adriana A. Rodriguez Alvarez Isabella F. Cieri Mounika Naidu Boya Shiv Patel Aniket Agrawal Sasha P. Suarez Ferreira Christianah Alli Shruti Sharma Anahita Dua |
author_sort | Adriana A. Rodriguez Alvarez |
collection | DOAJ |
description | IntroductionInflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple diseases and can thus, also impact recovery post-treatment and surgical outcomes. Yet, there is a paucity of data regarding the relationship between inflammatory biomarkers and arterial thrombotic potential in peripheral artery disease (PAD) patients post-revascularization. Our pilot study attempts to fill this gap by evaluating if the expression of inflammatory biomarkers in PAD patients correlates with the incidence of thrombotic events post-revascularization.MethodsPlasma samples were prospectively collected from PAD patients who underwent revascularization from 2021 to 2023 at monthly time points for 6 months from the procedure. Patients were followed for a total of 6 months post-procedure and those who experienced thrombotic events were identified. Nine patients with thrombotic events and 16 with non-thrombotic events along with 5 healthy volunteers were analyzed. Plasma samples were analyzed for the following pro-inflammatory markers: IL-1β (Interleukin-1 beta), IL-6, and TNF-α (Tumor Necrosis Factor - alpha), GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), IFNγ (Interferon-gamma), IL-8, MCP-1 (Monocyte Chemoattractant Protein-1). The Kruskal-Wallis test was performed to compare bio-inflammatory marker levels between groups.ResultsA total of 303 patients were enrolled, of which 59 had thrombotic events. There were no differences between medications or disease burden between groups. Levels of circulating IL-6 and TNF- α were significantly higher in the thrombosis cohort compared to the non-thrombosis cohort (55 vs. 38, p < 0.02) and (159 vs. 110, p < 0.02) respectively. Although there was a trend toward significance for IL-1β between the thrombotic cohort and non-thrombotic cohort, it did not reach statistical significance (18 vs. 11.5, p = NS). There was no difference observed in aspirin’s ability to dampen the inflammatory response between the two groups as all patients were on aspirin between the groups evaluated.ConclusionPro-inflammatory markers IL-6 and TNF-α are significantly increased in patients, 1 month prior to an arterial thrombotic event, as compared to patients without thrombotic events. These biomarkers could predict impending thrombosis in patients with PAD post-revascularization. |
format | Article |
id | doaj-art-a58e1a8f9d0144c6b1ece1e73c9c3ce0 |
institution | Matheson Library |
issn | 2296-858X |
language | English |
publishDate | 2025-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj-art-a58e1a8f9d0144c6b1ece1e73c9c3ce02025-07-24T05:33:21ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-07-011210.3389/fmed.2025.16158161615816Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularizationAdriana A. Rodriguez Alvarez0Isabella F. Cieri1Mounika Naidu Boya2Shiv Patel3Aniket Agrawal4Sasha P. Suarez Ferreira5Christianah Alli6Shruti Sharma7Anahita Dua8Division of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesDepartment of Immunology, Tufts University School of Medicine, Boston, MA, United StatesDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United StatesIntroductionInflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple diseases and can thus, also impact recovery post-treatment and surgical outcomes. Yet, there is a paucity of data regarding the relationship between inflammatory biomarkers and arterial thrombotic potential in peripheral artery disease (PAD) patients post-revascularization. Our pilot study attempts to fill this gap by evaluating if the expression of inflammatory biomarkers in PAD patients correlates with the incidence of thrombotic events post-revascularization.MethodsPlasma samples were prospectively collected from PAD patients who underwent revascularization from 2021 to 2023 at monthly time points for 6 months from the procedure. Patients were followed for a total of 6 months post-procedure and those who experienced thrombotic events were identified. Nine patients with thrombotic events and 16 with non-thrombotic events along with 5 healthy volunteers were analyzed. Plasma samples were analyzed for the following pro-inflammatory markers: IL-1β (Interleukin-1 beta), IL-6, and TNF-α (Tumor Necrosis Factor - alpha), GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), IFNγ (Interferon-gamma), IL-8, MCP-1 (Monocyte Chemoattractant Protein-1). The Kruskal-Wallis test was performed to compare bio-inflammatory marker levels between groups.ResultsA total of 303 patients were enrolled, of which 59 had thrombotic events. There were no differences between medications or disease burden between groups. Levels of circulating IL-6 and TNF- α were significantly higher in the thrombosis cohort compared to the non-thrombosis cohort (55 vs. 38, p < 0.02) and (159 vs. 110, p < 0.02) respectively. Although there was a trend toward significance for IL-1β between the thrombotic cohort and non-thrombotic cohort, it did not reach statistical significance (18 vs. 11.5, p = NS). There was no difference observed in aspirin’s ability to dampen the inflammatory response between the two groups as all patients were on aspirin between the groups evaluated.ConclusionPro-inflammatory markers IL-6 and TNF-α are significantly increased in patients, 1 month prior to an arterial thrombotic event, as compared to patients without thrombotic events. These biomarkers could predict impending thrombosis in patients with PAD post-revascularization.https://www.frontiersin.org/articles/10.3389/fmed.2025.1615816/fullinflammationperipheral artery disease (PAD)tumor necrosis factor-alphainterleukin-6thrombosis |
spellingShingle | Adriana A. Rodriguez Alvarez Isabella F. Cieri Mounika Naidu Boya Shiv Patel Aniket Agrawal Sasha P. Suarez Ferreira Christianah Alli Shruti Sharma Anahita Dua Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization Frontiers in Medicine inflammation peripheral artery disease (PAD) tumor necrosis factor-alpha interleukin-6 thrombosis |
title | Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
title_full | Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
title_fullStr | Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
title_full_unstemmed | Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
title_short | Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
title_sort | pro inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization |
topic | inflammation peripheral artery disease (PAD) tumor necrosis factor-alpha interleukin-6 thrombosis |
url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1615816/full |
work_keys_str_mv | AT adrianaarodriguezalvarez proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT isabellafcieri proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT mounikanaiduboya proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT shivpatel proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT aniketagrawal proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT sashapsuarezferreira proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT christianahalli proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT shrutisharma proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization AT anahitadua proinflammatorymarkersaspredictorsofarterialthrombosisinagedpatientswithperipheralarterialdiseasepostrevascularization |